Why Hematocrit Rises
Hematocrit measures the percentage of your blood that is composed of red blood cells. Normal range for men is 38.3-48.6%. Testosterone stimulates erythropoietin production in the kidneys, which increases red blood cell production. This is a known and expected effect of TRT. For many men, the increase is modest and stays within normal limits. For some, hematocrit rises above 50% and requires attention.
Higher red blood cell count means better oxygen delivery to tissues, which partly explains the improved energy and exercise performance men experience on TRT. But when hematocrit gets too high, blood viscosity increases, raising the risk of blood clots and cardiovascular events.
Normal vs Concerning Levels
| Hematocrit | Assessment | Action |
|---|---|---|
| 38-48% | Normal range | Continue monitoring |
| 48-50% | Upper normal, expected on TRT | Monitor more frequently |
| 50-52% | Elevated, approaching threshold | Consider dose adjustment or phlebotomy |
| 52-54% | High, requires intervention | Dose reduction, phlebotomy, hydration |
| Above 54% | Concerning, treatment modification needed | Pause TRT until resolved, evaluate |
Ready to put numbers behind it?
At-home lab kit, licensed provider review, and a protocol that's actually built around your labs — not a template.
Decode every number on your lab report
The 7 biomarkers every man over 30 should track — and what their numbers actually mean. 8 pages, instant download.
Get the Free GuideRisk Factors
Certain men are more prone to hematocrit elevation on TRT. Risk factors include higher TRT doses, infrequent injections with large peaks, living at high altitude, sleep apnea especially untreated, smoking, and dehydration. Men with baseline hematocrit above 48% before starting TRT should be monitored more closely.
Management Options
Several strategies can manage elevated hematocrit without discontinuing TRT. Therapeutic phlebotomy, essentially donating blood, immediately reduces hematocrit by removing red blood cells. This can be done at a blood bank or medical facility every eight to twelve weeks as needed. Dose reduction or more frequent smaller injections can prevent excessive peaks that drive erythropoiesis. Adequate hydration plays a meaningful role since dehydration concentrates the blood and artificially elevates hematocrit readings. Naringin, a grapefruit flavonoid, has shown some evidence of modestly reducing hematocrit though the evidence is preliminary.
Monitoring Schedule
Hematocrit should be checked at baseline before starting TRT, at six weeks after starting, at three months, at six months, and then every six months thereafter. If your hematocrit trend is consistently upward, increase monitoring frequency and discuss protocol modifications with your provider. The goal is to maintain the benefits of TRT while keeping hematocrit in a safe range.
This article is informed by peer-reviewed research and clinical guidelines:
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med 2023;389:107-117. View study →
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol 2018;200:423-432. View guideline →
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018;103:1715-1744. View guideline →
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men (Testosterone Trials). N Engl J Med 2016;374:611-624. View study →
All Heyday Health content is reviewed by licensed providers and updated when clinical guidelines change. See our medical team for review credentials.